Results

Total Results: 3,870 records

Showing results for "disease".

81. Your Guide to Preventing and Treating Blood Clots | Agency for Healthcare Research and Quality
    www.ahrq.gov/patients-consumers/prevention/disease/bloodclots.html
    August 01, 2017 - Your Guide to Preventing and Treating Blood Clots Blood clots are a serious medical condition. It is important to know the signs and get treated right away. This guide describes ways to prevent and treat blood clots; symptoms; and medication side effects as well as when to go to the emergency room. …

82. Su guía para evitar y tratar la formación de coágulos | Agency for Healthcare Research and Quality
    www.ahrq.gov/patients-consumers/prevention/disease/spblclots.html
    August 01, 2017 - Su guía para evitar y tratar la formación de coágulos Los coágulos son serios. Es importante saber los señales y conseguir tratado enseguida. Esta guía describe maneras de prevenir y de tratar coágulos; síntomas; y efectos secundarios de la medicación así como cuándo ir a la sala de urgencias. Est…

83. Designing and Implementing Medicaid Disease and Care Management Programs | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/medicaidmgmt/index.html
    October 01, 2014 - Designing and Implementing Medicaid Disease and Care Management Programs Next Page Table … of Contents Designing and Implementing Medicaid Disease and Care Management Programs Introduction …       Review Synopsis: Coronary Artery Disease Appendix: State Overviews Disclaimer This User's … Ashley Fox, Disease Management Program Specialist, Texas Health and Human Services Commission. … Mary Miller, Program Manager/Disease Management, Illinois Department of Healthcare and Family Services

84. July 17 Webinar: Empower Patients Through Digital Healthcare Tools | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/963.html
    June 01, 2025 - Chronic Liver Disease Projected To Increase Significantly by 2050 . … Chronic Liver Disease Projected To Increase Significantly by 2050 Metabolic dysfunction-associated steatotic … liver disease (MASLD), the most common cause of chronic liver disease, could affect 41.4 percent of … authors, these findings should inform health systems’ decisions and planning to prevent and treat liver disease … an average of $100 billion annually to treat key diet-related conditions, including cardiovascular disease

85. Table 28. Logistic regression of characteristics associated with utilization of education and case management visits by adults with diabetes or cardiovascular disease. | Agency for Healthcare Research and Quality
    www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chap6tab28.html
    December 01, 2017 - with utilization of education and case management visits by adults with diabetes or cardiovascular disease …       Other chronic conditions 1.57 0.002 Hypertension 0.87 0.164 Renal disease … /failure 1.20 0.001 Mental health disorder 1.00 0.973 Liver disease 0.74 0.084 … CVD: Cardiovascular disease Return to Chapter 5 Related Content Advanced Methods in

86. Table 27. Utilization of education and case management (ECM) visits among adults with diabetes or cardiovascular disease by patient characteristics. All project sites. Fisca | Agency for Healthcare Research and Quality
    www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chap6tab27.html
    December 01, 2017 - Utilization of education and case management (ECM) visits among adults with diabetes or cardiovascular disease … 4.5 CVD and diabetes 1.5 44.2% 3.4 Hypertension 1.1 36.9% 3.0 Renal disease … /failure 1.1 34.7% 3.2 Mental health disorder 1.1 36.4% 3.1 Liver disease 1.0 … CVD: Cardiovascular disease; IHS: Indian Health Service Return to Chapter 5

87. Q-METRIC Sickle Cell Disease Measure 1, Section 8, Tables 7, 8, and 9 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-8-table-7-8-9.pdf
    October 01, 2013 - Q-METRIC Sickle Cell Disease Measure 1, Section 8, Tables 7, 8, and 9   … Q-METRIC Sickle Cell Disease Measure 1: Timeliness of Confirmatory Testing … for Sickle Cell Disease Graphics for Section VIII Feasibility VIII.A. … Abbreviations: SCD = sickle cell disease; HPLC = high performance liquid chromatography; Hgb = hemoglobin … ; IEF = iso-electric focusing; SCDAA-MI = Sickle Cell Disease Association of America- Michigan Chapter

88. Appendix D. Clinical-Community Relationships Measures Instruments (16-23) | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/resources/chronic-care/clinical-community-relationships-measures-atlas/ccrm-atlasapd6d.html
    March 01, 2013 - Manual—Second Version Continuity of Care Practices Survey—Practice Level [CCPS-P] Capacity for Chronic Disease … Interview—Linkages with External Organisations of Providers (GP-LI) 109 Capacity for Chronic Disease

89. Appendix D. Clinical-Community Relationships Measures Instruments (5-10) | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/resources/chronic-care/clinical-community-relationships-measures-atlas/ccrm-atlasapd6b.html
    March 01, 2013 - Manual—Second Version Continuity of Care Practices Survey—Practice Level [CCPS-P] Capacity for Chronic Disease … Interview—Linkages with External Organisations of Providers (GP-LI) 109 Capacity for Chronic Disease

90. Appendix D. Clinical-Community Relationships Measures Instruments (11-15) | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/resources/chronic-care/clinical-community-relationships-measures-atlas/ccrm-atlasapd6c.html
    March 01, 2013 - Manual—Second Version Continuity of Care Practices Survey—Practice Level [CCPS-P] Capacity for Chronic Disease … Interview—Linkages with External Organisations of Providers (GP-LI) 109 Capacity for Chronic Disease

91. Morgan, Daniel | Agency for Healthcare Research and Quality
    www.ahrq.gov/funding/training-grants/grants/active/kawards/Kawdsummorg.html
    October 01, 2014 - Institution: University of Maryland, Baltimore Grant Title: Improving Patient Safety and Disease … This was followed by a Clinical Fellow appointment in International Medicine and Infectious Diseases … The grantee is committed to a career in academic medicine as an infectious disease epidemiologist. … Specific Accomplishments: Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases

92. Statistical Brief Highlights Cost of Heart Disease | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/968.html
    July 01, 2025 - Statistical Brief Highlights Cost of Heart Disease Issue Number 968 AHRQ News Now is a weekly … July 29, 2025 Today’s Headlines: Statistical Brief Highlights Cost of Heart Disease . … Statistical Brief Highlights Cost of Heart Disease In the United States, the cost of treating adults … with heart disease totaled $100 billion in 2022. … Explore the impact of heart disease by insurance type, service, and more. 

93. Table 5. Evidence Supporting Emergency Department Pain Assessment for Children With Sickle Cell Disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-section-5-table-5.pdf
    April 01, 2014 - Evidence Supporting Emergency Department Pain Assessment for Children With Sickle Cell Disease Q‐METRIC … Table 5: Evidence Supporting Emergency Department Pain Assessment for Children with Sickle Cell Disease … The Management of Sickle Cell Disease. National Institutes of Health. Bethesda, MD, 2002. … Management of vaso‐ occlusive pain events in sickle cell disease. … Management of sickle cell disease. N Engl J Med 1999; 340(13):1021‐1030.

94. Study Identifies Trends in Attention Deficit Hyperactivity Disorder Medication Misuse | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/969.html
    August 01, 2025 - AHRQ Stats: Prevalence of Heart Disease Treatment by Age .   New Research and Evidence . … AHRQ Stats: Prevalence of Heart Disease Treatment by Age  Adults aged 65 and older were most likely to … receive treatment for heart disease in 2022, with 22.8 percent having treatment. … Source: AHRQ Medical Expenditure Panel Survey Statistical Brief #562,  Healthcare Expenditures for Heart Disease … Review (draft open for comment through August 7): The Performance of Fusion Procedures for Degenerative Disease

95. Hospital Deaths for Common Heart Conditions Increased While Hospitalizations Decreased During the First Year of COVID-19 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/qdr-data-spotlight-heart-failure-hospital.pdf
    July 01, 2023 - Diseases affecting the heart valves; 4. Diseases affecting pulmonary circulation; 5. … Diseases affecting the heart’s electrical conduction system, or “arrhythmias”; and 6. … iiThis report groups together International Classification of Diseases, 10th Revision, Clinical Modification … of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) … ◆ Diseases of the heart valves (ICD-10-CM I34-I38) include conditions that affect the membranous

96. Appropriate Emergency Department Blood Testing for Children with Sickle Cell Disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-215-fullreport.pdf
    August 01, 2017 - Appropriate Emergency Department Blood Testing for Children with Sickle Cell Disease Appropriate Emergency … Department Blood Testing for Children with Sickle Cell Disease Section 1. … This measure is part of the Q-METRIC Sickle Cell Disease Measures collection. 2. … This measure is part of the Q-METRIC Sickle Cell Disease Medical Record Data set. 3. … addressing childhood obesity may have implications for the subsequent development of cardiovascular diseases

97. Appropriate Emergency Department Pain Assessment for Children With Sickle Cell Disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-fullreport.pdf
    April 01, 2018 - addressing childhood obesity may have implications for the subsequent development of cardiovascular diseases … Centers for Disease Control and Prevention. … Management of vaso‐occlusive pain events in sickle cell disease. … Population estimates of sickle cell disease in the U.S. … Quality‐of‐care indicators for children with sickle cell disease.

98. Appropriate Emergency Department Fever Management for Children With Sickle Cell Disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-216-fullreport.pdf
    February 01, 2018 - addressing childhood obesity may have implications for the subsequent development of cardiovascular diseases … work against a wider number of bacterial types and so may be used to treat a variety of infectious diseases … Population estimates of sickle cell disease in the U.S. … Management of sickle cell disease. … Quality‐of‐care indicators for children with sickle cell disease.

99. Acknowledgments | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/final-reports/ptmgmt/acknowledgements.html
    July 01, 2018 - Claudette Bean, RN Director of Disease Management Systems Medical Care Development George Bennett … of Family and Community Medicine University of California, San Francisco Karen Brey Director of Disease … Management Institute Harry Leider, MD Chief Medical Officer, XLHealth Alfred Lewis President Disease … John Seidenfield, MD Medical Director Anthem Blue Cross Blue Shield Christobel Selecky President, Disease

100. Section 1, Tables 1 to 3 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-216-scd-fever-section-1-tables-1-3.pdf
     June 02, 2025 - Section 1, Tables 1 to 3 Table 1: Codes to Identify Sickle Cell Disease Condition Name Hemoglobin … ) Hb beta zero‐thalassemia Hb F only 282.49 Hb S beta‐thalassemia Hb F,S,A 282.41, 282.42 Hb SC‐disease … Hb F,S,C 282.63, 282.64 Hb SD‐disease Hb F,S,D 282.68, 282.69 Hb SS‐disease (sickle cell anemia) Hb … Hb F,C,A 282.49 Hb D beta‐thalassemia Hb F,D,A 282.49 Hb E beta‐thalassemia Hb F,E,A 282.49 Hb C‐disease … Hb F,C 282.7 Hb E‐disease Hb F,E 282.7 Hb H‐disease Hb F,H 282.49 Hb SE‐disease Hb F,S,E 282.68,